These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8281712)

  • 1. Goserelin treatment in glandular hyperplasia.
    Garozzo G; La Greca M; Lomeo E; Panella M
    Clin Exp Obstet Gynecol; 1993; 20(4):268-72. PubMed ID: 8281712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of endometrial hyperplasia with Goserelin depot, an LH-RH analog].
    Pozzi M; Castagnola D; Cherubini F
    Minerva Ginecol; 1993 May; 45(5):251-4. PubMed ID: 8351064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding.
    Colacurci N; De Placido G; Galasso M; Mollo A; Perino A; Cittadini E
    Acta Eur Fertil; 1991; 22(4):229-31. PubMed ID: 1844328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding.
    Colacurci N; De Placido G; Mollo A; Perino A; Cittadini E
    Clin Exp Obstet Gynecol; 1995; 22(3):212-9. PubMed ID: 7554259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
    Candiani GB; Vercellini P; Fedele L; Arcaini L; Bianchi S; Candiani M
    Acta Obstet Gynecol Scand; 1990; 69(5):413-5. PubMed ID: 2148663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hysteroscopic endometrial reduction. Analysis of 85 cases].
    Luneau F; Boubli L; Nadal F; Bautrant E; Blanc B
    Rev Fr Gynecol Obstet; 1992 May; 87(5):260-6. PubMed ID: 1626171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex].
    Tiufekchieva E; Nikolov A
    Akush Ginekol (Sofiia); 2002; 41(2):30-4. PubMed ID: 12066549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
    Ivanov S; Kovachev E; Tsonev A; Abbud A
    Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional uterine bleeding (DUB).
    Bulletti C; Flamigni C; Prefetto RA; Polli V; Giacomucci E
    Ann N Y Acad Sci; 1994 Sep; 734():80-90. PubMed ID: 7978956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a GnRH analogue in the treatment of certain forms of endometrial hyperplasia associated with menometrorrhagia].
    Bonfirraro G; Sanna B; De Marco A; Chieffi O; Bonfirraro PP; Orlando V
    Minerva Ginecol; 1995 Oct; 47(10):467-70. PubMed ID: 8559438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin releasing hormone agonist for chronic anovulatory uterine bleeding and severe anemia.
    Vercellini P; Fedele L; Maggi R; Vendola N; Bocciolone L; Colombo A
    J Reprod Med; 1993 Feb; 38(2):127-9. PubMed ID: 8445603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
    Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
    J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Menorrhagia, metrorrhagia and the endometrium. Apropos of 300 cases].
    Delarue T; Baty A; Foissey A
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(1):57-64. PubMed ID: 3351206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection.
    Vercellini P; Trespidi L; Bramante T; Panazza S; Mauro F; Crosignani PG
    Int J Gynaecol Obstet; 1994 Jun; 45(3):235-9. PubMed ID: 7926242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
    Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
    Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
    West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
    Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Sowter MC; Lethaby A; Singla AA
    Cochrane Database Syst Rev; 2002; (3):CD001124. PubMed ID: 12137619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
    Reichel RP; Schweppe KW
    Fertil Steril; 1992 Jun; 57(6):1197-202. PubMed ID: 1534773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.